(Tyr0)-prepro-atrial natriuretic factor (104-123) (human) contains an added aromatic residue that enhances spectroscopic monitoring and structural probing. Its sequence supports folding and receptor-interaction analyses. Charged residues contribute to aqueous behavior. Researchers use it in motif-mapping studies of natriuretic peptides.
CAT No: A17055
CAS No:309245-24-7
Synonyms/Alias:(Tyr0)-prepro-atrial natriuretic factor (104-123) (human);309245-24-7;(TYR0)-PREPRO-ATRIAL NATRIURETIC FACTOR (104-123) (HUMAN);(Tyr0)-kaliuretic peptide(human);FT109523;(Tyr?)-Kaliuretic Peptide (human), (Tyr?)-pro-hANF (79-98), (Tyr?)-Prepro-Atrial Natriuretic Factor (103-122) (bovine);(Tyr0)-Prepro-Atrial Natriuretic Factor (104-123) (human) H-Tyr-Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr- Ala-Pro-Arg-OH;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.